Hand and foot syndrome secondary to capecitabine
暂无分享,去创建一个
[1] H. Komatsu,et al. Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: A qualitative study. , 2019, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[2] Hina Lal. Hand and foot syndrome secondary to capecitabine. , 2014, Indian Journal of Dermatology, Venereology and Leprology.
[3] Sudhir Kumar,et al. Capecitabine-induced hand-foot syndrome , 2014 .
[4] J. Zekri,et al. Hyperpigmentation of the tongue, palms and soles: Rare side effect of capecitabine , 2013 .
[5] Gabriella Fabbrocini,et al. Chemotherapy and skin reactions , 2012, Journal of experimental & clinical cancer research : CR.
[6] G. Casas,et al. Cutaneous manifestations of new oncologic drugs: epidermal growth factor receptor inhibitors and 5-fl uorouracil prodrugs , 2010 .
[7] R. Elledge,et al. A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] M. Summerhayes,et al. The “Handfoot Syndrome” occurring with chronic administration of Etoposide , 1992, European journal of haematology.
[9] H. Gadner,et al. Toxic skin reaction restricted to palms and soles after high-dose methotrexate. , 1991, Pediatric hematology and oncology.
[10] J. Lokich,et al. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. , 1984, Annals of internal medicine.